1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Yuan, X.
Downing, A.K.
Knott, V.
Handford, P.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
EMBO J.
EMJODG
0897
0261-4189
16
6659
6666
10.1093/emboj/16.22.6659
9362480
Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.
1997
10.2210/pdb1apj/pdb
pdb_00001apj
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
8018.965
FIBRILLIN
TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN 6(TB6), RESIDUES 2054 - 2125
1
man
polymer
no
no
SAQDLRMSYCYAKFEGGKCSSPKSRNHSKQECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSA
SAQDLRMSYCYAKFEGGKCSSPKSRNHSKQECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN 6(TB6), RESIDUES 2054-2125
9606
Homo sapiens
562
Escherichia coli
NM554
PQE30
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-01-28
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1997-07-22
REL
21
BRUNGER
refinement
X-PLOR
3.1
SER
1
n
1
SER
1
A
ALA
2
n
2
ALA
2
A
GLN
2054
n
3
GLN
2054
A
ASP
2055
n
4
ASP
2055
A
LEU
2056
n
5
LEU
2056
A
ARG
2057
n
6
ARG
2057
A
MET
2058
n
7
MET
2058
A
SER
2059
n
8
SER
2059
A
TYR
2060
n
9
TYR
2060
A
CYS
2061
n
10
CYS
2061
A
TYR
2062
n
11
TYR
2062
A
ALA
2063
n
12
ALA
2063
A
LYS
2064
n
13
LYS
2064
A
PHE
2065
n
14
PHE
2065
A
GLU
2066
n
15
GLU
2066
A
GLY
2067
n
16
GLY
2067
A
GLY
2068
n
17
GLY
2068
A
LYS
2069
n
18
LYS
2069
A
CYS
2070
n
19
CYS
2070
A
SER
2071
n
20
SER
2071
A
SER
2072
n
21
SER
2072
A
PRO
2073
n
22
PRO
2073
A
LYS
2074
n
23
LYS
2074
A
SER
2075
n
24
SER
2075
A
ARG
2076
n
25
ARG
2076
A
ASN
2077
n
26
ASN
2077
A
HIS
2078
n
27
HIS
2078
A
SER
2079
n
28
SER
2079
A
LYS
2080
n
29
LYS
2080
A
GLN
2081
n
30
GLN
2081
A
GLU
2082
n
31
GLU
2082
A
CYS
2083
n
32
CYS
2083
A
CYS
2084
n
33
CYS
2084
A
CYS
2085
n
34
CYS
2085
A
ALA
2086
n
35
ALA
2086
A
LEU
2087
n
36
LEU
2087
A
LYS
2088
n
37
LYS
2088
A
GLY
2089
n
38
GLY
2089
A
GLU
2090
n
39
GLU
2090
A
GLY
2091
n
40
GLY
2091
A
TRP
2092
n
41
TRP
2092
A
GLY
2093
n
42
GLY
2093
A
ASP
2094
n
43
ASP
2094
A
PRO
2095
n
44
PRO
2095
A
CYS
2096
n
45
CYS
2096
A
GLU
2097
n
46
GLU
2097
A
LEU
2098
n
47
LEU
2098
A
CYS
2099
n
48
CYS
2099
A
PRO
2100
n
49
PRO
2100
A
THR
2101
n
50
THR
2101
A
GLU
2102
n
51
GLU
2102
A
PRO
2103
n
52
PRO
2103
A
ASP
2104
n
53
ASP
2104
A
GLU
2105
n
54
GLU
2105
A
ALA
2106
n
55
ALA
2106
A
PHE
2107
n
56
PHE
2107
A
ARG
2108
n
57
ARG
2108
A
GLN
2109
n
58
GLN
2109
A
ILE
2110
n
59
ILE
2110
A
CYS
2111
n
60
CYS
2111
A
PRO
2112
n
61
PRO
2112
A
TYR
2113
n
62
TYR
2113
A
GLY
2114
n
63
GLY
2114
A
SER
2115
n
64
SER
2115
A
GLY
2116
n
65
GLY
2116
A
ILE
2117
n
66
ILE
2117
A
ILE
2118
n
67
ILE
2118
A
VAL
2119
n
68
VAL
2119
A
GLY
2120
n
69
GLY
2120
A
PRO
2121
n
70
PRO
2121
A
ASP
2122
n
71
ASP
2122
A
ASP
2123
n
72
ASP
2123
A
SER
2124
n
73
SER
2124
A
ALA
2125
n
74
ALA
2125
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
SER
2059
A
N
SER
8
A
O
HIS
2078
A
O
HIS
27
A
O
GLU
2097
A
O
GLU
46
A
N
TRP
2092
A
N
TRP
41
A
O
GLY
2091
A
O
GLY
40
A
N
TYR
2062
A
N
TYR
11
A
N
ALA
2063
A
N
ALA
12
A
O
SER
2072
A
O
SER
21
1
A
ARG
2057
0.290
SIDE CHAIN
1
A
ARG
2076
0.254
SIDE CHAIN
2
A
ARG
2057
0.202
SIDE CHAIN
2
A
ARG
2076
0.191
SIDE CHAIN
2
A
ARG
2108
0.306
SIDE CHAIN
3
A
ARG
2057
0.103
SIDE CHAIN
3
A
ARG
2076
0.306
SIDE CHAIN
4
A
ARG
2057
0.117
SIDE CHAIN
4
A
ARG
2076
0.163
SIDE CHAIN
5
A
ARG
2057
0.255
SIDE CHAIN
5
A
ARG
2076
0.209
SIDE CHAIN
5
A
ARG
2108
0.171
SIDE CHAIN
6
A
ARG
2057
0.211
SIDE CHAIN
6
A
ARG
2076
0.303
SIDE CHAIN
6
A
ARG
2108
0.141
SIDE CHAIN
7
A
ARG
2057
0.114
SIDE CHAIN
7
A
ARG
2076
0.250
SIDE CHAIN
7
A
ARG
2108
0.298
SIDE CHAIN
8
A
ARG
2057
0.284
SIDE CHAIN
8
A
ARG
2076
0.286
SIDE CHAIN
8
A
ARG
2108
0.304
SIDE CHAIN
9
A
ARG
2057
0.225
SIDE CHAIN
9
A
ARG
2076
0.251
SIDE CHAIN
9
A
ARG
2108
0.296
SIDE CHAIN
10
A
ARG
2057
0.156
SIDE CHAIN
10
A
ARG
2108
0.281
SIDE CHAIN
11
A
ARG
2057
0.078
SIDE CHAIN
11
A
ARG
2076
0.235
SIDE CHAIN
11
A
ARG
2108
0.084
SIDE CHAIN
12
A
ARG
2057
0.206
SIDE CHAIN
12
A
ARG
2076
0.200
SIDE CHAIN
12
A
ARG
2108
0.304
SIDE CHAIN
13
A
ARG
2057
0.254
SIDE CHAIN
13
A
ARG
2076
0.262
SIDE CHAIN
13
A
ARG
2108
0.261
SIDE CHAIN
14
A
ARG
2057
0.306
SIDE CHAIN
14
A
ARG
2076
0.300
SIDE CHAIN
14
A
ARG
2108
0.234
SIDE CHAIN
15
A
ARG
2057
0.267
SIDE CHAIN
15
A
ARG
2076
0.207
SIDE CHAIN
16
A
ARG
2057
0.236
SIDE CHAIN
16
A
ARG
2076
0.290
SIDE CHAIN
17
A
ARG
2057
0.135
SIDE CHAIN
17
A
ARG
2076
0.291
SIDE CHAIN
17
A
ARG
2108
0.306
SIDE CHAIN
18
A
ARG
2057
0.277
SIDE CHAIN
18
A
ARG
2076
0.228
SIDE CHAIN
18
A
ARG
2108
0.266
SIDE CHAIN
19
A
ARG
2057
0.291
SIDE CHAIN
19
A
ARG
2076
0.308
SIDE CHAIN
19
A
ARG
2108
0.223
SIDE CHAIN
20
A
ARG
2057
0.265
SIDE CHAIN
20
A
ARG
2108
0.295
SIDE CHAIN
21
A
ARG
2076
0.182
SIDE CHAIN
1
A
LEU
2056
27.72
47.26
1
A
SER
2059
-113.14
-163.17
1
A
GLU
2066
-91.20
57.24
1
A
SER
2072
70.95
56.65
1
A
CYS
2085
-106.64
-62.71
1
A
LYS
2088
28.10
73.66
1
A
CYS
2096
-28.10
125.51
1
A
SER
2115
-54.92
88.44
1
A
ILE
2117
51.05
-85.92
1
A
VAL
2119
-36.66
116.29
1
A
ASP
2122
43.92
27.58
1
A
SER
2124
158.49
165.56
2
A
ALA
2
53.12
-178.36
2
A
LEU
2056
38.18
41.90
2
A
SER
2059
-116.44
-159.24
2
A
SER
2079
-41.64
153.55
2
A
LYS
2088
30.45
77.60
2
A
CYS
2096
-27.22
123.81
2
A
PRO
2103
-92.62
31.78
2
A
SER
2115
-100.60
67.23
2
A
ILE
2117
-26.12
-77.87
2
A
ILE
2118
167.12
66.32
2
A
ASP
2122
87.29
-47.43
2
A
SER
2124
59.48
97.11
3
A
ALA
2
173.68
-161.08
3
A
GLN
2054
-49.03
-174.82
3
A
ASP
2055
-89.00
45.79
3
A
LEU
2056
45.65
22.94
3
A
SER
2059
-120.47
-161.25
3
A
LYS
2088
31.00
70.12
3
A
CYS
2096
-27.45
111.28
3
A
LEU
2098
-35.39
95.29
3
A
PRO
2103
-94.04
31.39
3
A
ILE
2117
49.16
-86.27
3
A
VAL
2119
-29.33
-37.53
3
A
SER
2124
-166.36
-56.94
4
A
ALA
2
65.92
139.11
4
A
ASP
2055
57.37
93.75
4
A
SER
2059
-107.59
-165.36
4
A
SER
2075
-37.62
-35.99
4
A
ARG
2076
-109.15
-169.43
4
A
LYS
2088
30.08
77.14
4
A
CYS
2096
-26.92
122.12
4
A
LEU
2098
-37.67
110.36
4
A
PRO
2103
-94.63
30.44
4
A
SER
2115
-47.37
88.25
4
A
ILE
2117
61.53
-86.65
4
A
VAL
2119
-29.53
-44.76
4
A
PRO
2121
-44.86
86.00
4
A
ASP
2122
38.22
38.74
5
A
ALA
2
69.17
129.19
5
A
LEU
2056
32.14
41.79
5
A
LYS
2088
29.08
67.83
5
A
CYS
2096
-27.34
124.18
5
A
LEU
2098
-31.83
116.78
5
A
SER
2115
-66.82
84.35
5
A
VAL
2119
-36.54
-34.86
5
A
PRO
2121
-62.25
87.66
5
A
ASP
2122
165.16
-27.79
5
A
ASP
2123
-118.17
70.92
5
A
SER
2124
-35.76
144.67
6
A
LEU
2056
36.33
47.42
6
A
SER
2059
-113.41
-161.34
6
A
SER
2079
-32.17
149.50
6
A
LYS
2088
25.96
73.32
6
A
CYS
2096
-27.38
119.79
6
A
LEU
2098
-31.99
131.82
6
A
PRO
2103
-93.19
33.91
6
A
ILE
2117
-147.64
-48.92
6
A
VAL
2119
-19.06
-47.10
6
A
PRO
2121
-44.49
96.02
6
A
ASP
2122
85.38
-40.69
6
A
ASP
2123
81.77
39.55
6
A
SER
2124
169.61
165.54
7
A
GLN
2054
-69.72
83.81
7
A
LEU
2056
30.91
43.32
7
A
SER
2072
68.93
60.41
7
A
LYS
2074
-39.91
125.22
7
A
CYS
2085
-125.70
-62.52
7
A
LYS
2088
44.89
90.53
7
A
CYS
2096
-27.26
126.67
7
A
SER
2115
-84.78
44.01
7
A
ILE
2117
-155.65
-40.23
7
A
ILE
2118
130.12
56.25
7
A
PRO
2121
-59.30
83.64
7
A
ASP
2122
33.76
32.79
7
A
ASP
2123
-90.18
39.03
7
A
SER
2124
-95.65
30.02
8
A
ALA
2
56.23
109.04
8
A
ASP
2055
44.70
28.68
8
A
LEU
2056
26.83
47.33
8
A
GLU
2066
-79.53
-167.62
8
A
SER
2072
79.49
60.32
8
A
LYS
2074
-82.95
45.18
8
A
SER
2075
34.02
-89.23
8
A
CYS
2085
-133.78
-41.54
8
A
LYS
2088
26.23
71.68
8
A
CYS
2096
-27.25
126.45
8
A
LEU
2098
-32.22
108.60
8
A
SER
2115
-45.41
87.43
8
A
VAL
2119
-32.47
-34.18
8
A
PRO
2121
-48.00
83.73
8
A
ASP
2123
45.70
82.28
8
A
SER
2124
-33.69
108.10
9
A
GLN
2054
-111.87
51.89
9
A
LEU
2056
29.70
47.28
9
A
SER
2059
-127.93
-160.67
9
A
LYS
2074
-50.42
-168.25
9
A
CYS
2085
-130.95
-36.24
9
A
CYS
2096
-27.05
120.42
9
A
SER
2115
-51.81
87.36
9
A
ILE
2117
52.93
-86.98
9
A
VAL
2119
-24.78
-84.21
9
A
PRO
2121
-82.86
43.13
9
A
ASP
2122
173.05
-31.26
9
A
SER
2124
-87.21
-86.91
10
A
LEU
2056
25.23
49.20
10
A
GLU
2066
-92.96
57.53
10
A
LYS
2074
-49.42
157.07
10
A
ARG
2076
-85.21
-158.58
10
A
LYS
2088
23.43
50.93
10
A
CYS
2096
-27.61
132.83
10
A
LEU
2098
-37.58
113.04
10
A
PRO
2103
-94.00
30.34
10
A
ILE
2117
32.42
34.23
10
A
ILE
2118
27.00
54.46
10
A
VAL
2119
-37.57
-27.76
10
A
ASP
2123
-86.86
39.83
11
A
ALA
2
58.48
-170.32
11
A
GLN
2054
-76.07
-169.70
11
A
LEU
2056
49.99
23.02
11
A
TYR
2060
-33.68
131.27
11
A
SER
2072
67.79
61.84
11
A
LYS
2088
56.76
72.24
11
A
CYS
2096
-27.23
122.91
11
A
LEU
2098
-34.39
114.85
11
A
SER
2115
-51.86
89.16
11
A
ILE
2117
56.43
-85.94
11
A
ILE
2118
-119.25
72.66
11
A
VAL
2119
-33.88
-32.76
11
A
PRO
2121
-67.35
81.47
11
A
SER
2124
36.94
95.52
12
A
ALA
2
51.24
-172.13
12
A
ASP
2055
-41.44
92.01
12
A
LEU
2056
-36.64
-27.15
12
A
SER
2079
-43.29
167.83
12
A
LYS
2088
31.27
84.88
12
A
CYS
2096
-27.45
125.11
12
A
PRO
2103
-95.16
33.55
12
A
ILE
2117
-20.56
-84.20
12
A
ILE
2118
174.72
42.61
12
A
ASP
2122
-155.62
-42.21
13
A
LEU
2056
31.01
36.17
13
A
GLU
2066
-85.48
48.82
13
A
LYS
2074
-53.43
-166.08
13
A
SER
2079
-34.16
154.45
13
A
LYS
2088
30.79
77.81
13
A
CYS
2096
-27.13
120.27
13
A
LEU
2098
-32.59
125.75
13
A
SER
2115
-45.32
80.35
13
A
ILE
2118
-94.02
-76.22
13
A
ASP
2122
33.96
31.98
13
A
ASP
2123
-99.49
40.44
14
A
GLN
2054
-114.49
59.51
14
A
LEU
2056
-95.77
39.46
14
A
ARG
2057
-27.35
148.83
14
A
SER
2059
-107.57
-161.03
14
A
LYS
2088
59.85
97.23
14
A
CYS
2096
-27.44
121.42
14
A
LEU
2098
-33.23
100.33
14
A
PRO
2103
-93.86
30.10
14
A
SER
2115
-40.54
89.63
14
A
ILE
2117
-13.39
-66.44
14
A
ILE
2118
145.41
53.11
14
A
ASP
2122
35.62
38.53
14
A
ASP
2123
-119.36
69.64
15
A
LEU
2056
36.33
44.44
15
A
SER
2059
-137.74
-158.87
15
A
ALA
2063
-32.81
-31.04
15
A
GLU
2066
-91.54
57.54
15
A
SER
2072
61.91
61.83
15
A
SER
2075
-37.67
-37.70
15
A
SER
2079
-31.15
143.68
15
A
LYS
2088
31.31
73.36
15
A
CYS
2096
-27.49
123.26
15
A
LEU
2098
-55.59
108.19
15
A
PRO
2103
-97.80
33.34
15
A
SER
2115
-101.06
63.25
15
A
ILE
2118
-91.86
-72.62
15
A
PRO
2121
-38.54
93.18
15
A
ASP
2122
159.34
-25.57
15
A
ASP
2123
-145.39
59.43
15
A
SER
2124
-178.95
-43.04
16
A
ALA
2
159.05
-172.28
16
A
SER
2072
82.83
59.31
16
A
LYS
2074
-58.29
173.29
16
A
SER
2079
-34.36
142.79
16
A
LYS
2088
30.03
82.37
16
A
CYS
2096
-27.92
107.88
16
A
LEU
2098
-35.16
118.19
16
A
PRO
2103
-91.05
30.61
16
A
SER
2115
-52.86
88.17
16
A
ILE
2117
-9.12
-70.67
16
A
ILE
2118
152.34
60.76
16
A
SER
2124
34.75
69.29
17
A
ASP
2055
47.05
29.80
17
A
LEU
2056
29.18
38.33
17
A
SER
2072
69.30
60.14
17
A
SER
2075
-39.20
-39.54
17
A
ARG
2076
-129.78
-163.30
17
A
LYS
2088
33.01
72.24
17
A
CYS
2096
-27.01
133.94
17
A
VAL
2119
-29.79
-37.01
17
A
ASP
2122
85.92
-35.66
17
A
SER
2124
-35.02
-75.47
18
A
ALA
2
169.07
136.87
18
A
ASP
2055
41.19
29.67
18
A
LEU
2056
29.05
44.53
18
A
SER
2059
-118.31
-159.53
18
A
LYS
2088
39.57
85.67
18
A
CYS
2096
-27.32
124.36
18
A
LEU
2098
-35.10
116.44
18
A
SER
2115
-51.92
88.17
18
A
ILE
2117
26.80
-82.50
18
A
ILE
2118
-111.24
75.63
18
A
PRO
2121
-43.79
84.53
18
A
ASP
2122
39.16
28.34
18
A
ASP
2123
51.82
75.52
18
A
SER
2124
-45.26
170.19
19
A
ASP
2055
35.85
32.41
19
A
LEU
2056
26.92
49.83
19
A
SER
2059
-128.16
-162.35
19
A
SER
2072
72.73
58.23
19
A
LYS
2088
32.13
69.66
19
A
CYS
2096
-27.06
129.64
19
A
LEU
2098
-37.40
106.79
19
A
SER
2115
-48.30
87.17
19
A
VAL
2119
-31.35
-38.05
19
A
SER
2124
-35.76
-75.17
20
A
ALA
2
63.40
-179.02
20
A
GLN
2054
-71.93
-151.12
20
A
SER
2072
71.10
59.64
20
A
SER
2079
-32.04
153.77
20
A
LYS
2088
34.50
74.43
20
A
CYS
2096
-27.29
121.25
20
A
LEU
2098
-32.75
127.42
20
A
SER
2115
-53.58
87.75
20
A
ILE
2118
-156.46
75.11
20
A
VAL
2119
-24.69
-67.23
20
A
PRO
2121
-58.63
89.57
20
A
ASP
2122
29.05
37.73
20
A
ASP
2123
-102.18
73.15
21
A
ASP
2055
34.31
32.00
21
A
LEU
2056
-107.66
72.00
21
A
ARG
2057
-28.85
134.26
21
A
ALA
2063
-39.85
-28.85
21
A
SER
2072
78.45
64.90
21
A
SER
2079
-36.22
154.12
21
A
LYS
2088
50.41
95.06
21
A
CYS
2096
-27.09
128.24
21
A
LEU
2098
-32.58
119.95
21
A
PRO
2103
-93.50
30.54
21
A
ASP
2104
-48.06
154.41
21
A
ILE
2117
-26.61
-82.83
21
A
ILE
2118
173.68
59.99
21
A
ASP
2122
33.36
38.10
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
NMR STUDY OF THE TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN (TB MODULE/8-CYS DOMAIN), NMR, 21 STRUCTURES
1
Y
N
A
LYS
2080
A
LYS
29
HELX_P
A
CYS
2084
A
CYS
33
1
H1
5
A
GLU
2105
A
GLU
54
HELX_P
A
ILE
2110
A
ILE
59
1
H2
6
disulf
2.020
A
CYS
2061
A
SG
CYS
10
1_555
A
CYS
2083
A
SG
CYS
32
1_555
disulf
2.016
A
CYS
2070
A
SG
CYS
19
1_555
A
CYS
2096
A
SG
CYS
45
1_555
disulf
2.025
A
CYS
2084
A
SG
CYS
33
1_555
A
CYS
2099
A
SG
CYS
48
1_555
disulf
2.019
A
CYS
2085
A
SG
CYS
34
1_555
A
CYS
2111
A
SG
CYS
60
1_555
EXTRACELLULAR MATRIX
FIBRILLIN FRAGMENT, MICROFIBRIL, TB MODULE, MARFAN SYNDROME, CONNECTIVE TISSUE, NOVEL FOLD, EXTRACELLULAR MATRIX
A
GLU
2102
A
GLU
51
1
A
PRO
2103
A
PRO
52
0.10
A
GLU
2102
A
GLU
51
2
A
PRO
2103
A
PRO
52
0.06
A
GLU
2102
A
GLU
51
3
A
PRO
2103
A
PRO
52
0.25
A
GLU
2102
A
GLU
51
4
A
PRO
2103
A
PRO
52
0.13
A
GLU
2102
A
GLU
51
5
A
PRO
2103
A
PRO
52
0.14
A
GLU
2102
A
GLU
51
6
A
PRO
2103
A
PRO
52
-0.06
A
GLU
2102
A
GLU
51
7
A
PRO
2103
A
PRO
52
0.06
A
GLU
2102
A
GLU
51
8
A
PRO
2103
A
PRO
52
0.02
A
GLU
2102
A
GLU
51
9
A
PRO
2103
A
PRO
52
0.14
A
GLU
2102
A
GLU
51
10
A
PRO
2103
A
PRO
52
0.13
A
GLU
2102
A
GLU
51
11
A
PRO
2103
A
PRO
52
0.19
A
GLU
2102
A
GLU
51
12
A
PRO
2103
A
PRO
52
0.21
A
GLU
2102
A
GLU
51
13
A
PRO
2103
A
PRO
52
-0.01
A
GLU
2102
A
GLU
51
14
A
PRO
2103
A
PRO
52
-0.04
A
GLU
2102
A
GLU
51
15
A
PRO
2103
A
PRO
52
0.25
A
GLU
2102
A
GLU
51
16
A
PRO
2103
A
PRO
52
0.05
A
GLU
2102
A
GLU
51
17
A
PRO
2103
A
PRO
52
0.02
A
GLU
2102
A
GLU
51
18
A
PRO
2103
A
PRO
52
-0.14
A
GLU
2102
A
GLU
51
19
A
PRO
2103
A
PRO
52
0.12
A
GLU
2102
A
GLU
51
20
A
PRO
2103
A
PRO
52
0.14
A
GLU
2102
A
GLU
51
21
A
PRO
2103
A
PRO
52
-0.08
FBN1_HUMAN
UNP
1
1
P35555
MRRGRLLEIALGFTVLLASYTSHGADANLEAGNVKETRASRAKRRGGGGHDALKGPNVCGSRYNAYCCPGWKTLPGGNQC
IVPICRHSCGDGFCSRPNMCTCPSGQIAPSCGSRSIQHCNIRCMNGGSCSDDHCLCQKGYIGTHCGQPVCESGCLNGGRC
VAPNRCACTYGFTGPQCERDYRTGPCFTVISNQMCQGQLSGIVCTKQLCCATVGRAWGHPCEMCPAQPHPCRRGFIPNIR
TGACQDVDECQAIPGLCQGGNCINTVGSFECKCPAGHKLNEVSQKCEDIDECSTIPGICEGGECTNTVSSYFCKCPPGFY
TSPDGTRCIDVRPGYCYTALTNGRCSNQLPQSITKMQCCCDAGRCWSPGVTVAPEMCPIRATEDFNKLCSVPMVIPGRPE
YPPPPLGPIPPVLPVPPGFPPGPQIPVPRPPVEYLYPSREPPRVLPVNVTDYCQLVRYLCQNGRCIPTPGSYRCECNKGF
QLDLRGECIDVDECEKNPCAGGECINNQGSYTCQCRAGYQSTLTRTECRDIDECLQNGRICNNGRCINTDGSFHCVCNAG
FHVTRDGKNCEDMDECSIRNMCLNGMCINEDGSFKCICKPGFQLASDGRYCKDINECETPGICMNGRCVNTDGSYRCECF
PGLAVGLDGRVCVDTHMRSTCYGGYKRGQCIKPLFGAVTKSECCCASTEYAFGEPCQPCPAQNSAEYQALCSSGPGMTSA
GSDINECALDPDICPNGICENLRGTYKCICNSGYEVDSTGKNCVDINECVLNSLLCDNGQCRNTPGSFVCTCPKGFIYKP
DLKTCEDIDECESSPCINGVCKNSPGSFICECSSESTLDPTKTICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLG
AAWGSPCTLCQVDPICGKGYSRIKGTQCEDIDECEVFPGVCKNGLCVNTRGSFKCQCPSGMTLDATGRICLDIRLETCFL
RYEDEECTLPIAGRHRMDACCCSVGAAWGTEECEECPMRNTPEYEELCPRGPGFATKEITNGKPFFKDINECKMIPSLCT
HGKCRNTIGSFKCRCDSGFALDSEERNCTDIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQRD
PLLCRGGVCHNTEGSYRCECPPGHQLSPNISACIDINECELSAHLCPNGRCVNLIGKYQCACNPGYHSTPDRLFCVDIDE
CSIMNGGCETFCTNSEGSYECSCQPGFALMPDQRSCTDIDECEDNPNICDGGQCTNIPGEYRCLCYDGFMASEDMKTCVD
VNECDLNPNICLSGTCENTKGSFICHCDMGYSGKKGKTGCTDINECEIGAHNCGKHAVCTNTAGSFKCSCSPGWIGDGIK
CTDLDECSNGTHMCSQHADCKNTMGSYRCLCKEGYTGDGFTCTDLDECSENLNLCGNGQCLNAPGGYRCECDMGFVPSAD
GKACEDIDECSLPNICVFGTCHNLPGLFRCECEIGYELDRSGGNCTDVNECLDPTTCISGNCVNTPGSYICDCPPDFELN
PTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPI
TVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCDDVNECETPGICGPGTCYNTVGNYTCICPPDYMQ
VNGGNNCMDMRRSLCYRNYYADNQTCDGELLFNMTKKMCCCSYNIGRAWNKPCEQCPIPSTDEFATLCGSQRPGFVIDIY
TGLPVDIDECREIPGVCENGVCINMVGSFRCECPVGFFYNDKLLVCEDIDECQNGPVCQRNAECINTAGSYRCDCKPGYR
FTSTGQCNDRNECQEIPNICSHGQCIDTVGSFYCLCHTGFKTNDDQTMCLDINECERDACGNGTCRNTIGSFNCRCNHGF
ILSHNNDCIDVDECASGNGNLCRNGQCINTVGSFQCQCNEGYEVAPDGRTCVDINECLLEPRKCAPGTCQNLDGSYRCIC
PPGYSLQNEKCEDIDECVEEPEICALGTCSNTEGSFKCLCPEGFSLSSSGRRCQDLRMSYCYAKFEGGKCSSPKSRNHSK
QECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSAVDMDECKEPDVCKHGQCINTDGSYRCECPFGYTLA
GNECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFRCVNTYGSYECKCPVGYVLRE
DRRMCKDEDECEEGKHDCTEKQMECKNLIGTYMCICGPGYQRRPDGEGCVDENECQTKPGICENGRCLNTRGSYTCECND
GFTASPNQDECLDNREGYCFTEVLQNMCQIGSSNRNPVTKSECCCDGGRGWGPHCEICPFQGTVAFKKLCPHGRGFMTNG
ADIDECKVIHDVCRNGECVNDRGSYHCICKTGYTPDITGTSCVDLNECNQAPKPCNFICKNTEGSYQCSCPKGYILQEDG
RSCKDLDECATKQHNCQFLCVNTIGGFTCKCPPGFTQHHTSCIDNNECTSDINLCGSKGICQNTPGSFTCECQRGFSLDQ
TGSSCEDVDECEGNHRCQHGCQNIIGGYRCSCPQGYLQHYQWNQCVDENECLSAHICGGASCHNTLGSYKCMCPAGFQYE
QFSGGCQDINECGSAQAPCSYGCSNTEGGYLCGCPPGYFRIGQGHCVSGMGMGRGNPEPPVSGEMDDNSLSPEACYECKI
NGYPKRGRKRRSTNETDASNIEDQSETEANVSLASWDVEKTAIFAFNISHVSNKVRILELLPALTTLTNHNRYLIESGNE
DGFFKINQKEGISYLHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH
2049
2125
1APJ
1
2125
P35555
A
1
1
74
1
ARG
engineered mutation
SER
1
1APJ
A
P35555
UNP
2052
1
1
CYS
engineered mutation
ALA
2
1APJ
A
P35555
UNP
2053
2
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
MET
2058
A
MET
7
A
SER
2059
A
SER
8
A
HIS
2078
A
HIS
27
A
SER
2079
A
SER
28
A
GLU
2097
A
GLU
46
A
LEU
2098
A
LEU
47
A
GLY
2091
A
GLY
40
A
TRP
2092
A
TRP
41
A
CYS
2061
A
CYS
10
A
PHE
2065
A
PHE
14
A
CYS
2070
A
CYS
19
A
PRO
2073
A
PRO
22
1
P 1